RNS Number : 7789Z Renalytix PLC 27 January 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix to Present at BTIG MedTech, Digital Health , Life Science & Diagnostic Tools Conference New York and SALT LAKE CITY , January 27, 2022 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today
American Journal of Nephrology data demonstrates KidneyIntelX successfully monitors patient response to SGLT2 therapy in 1,325 CANagliflozin CardioVAScular Assessment Study (CANVAS) multinational clinical trial cohort patients NEW YORK and SALT LAKE CITY, Jan.
RNS Number : 1056Y Renalytix PLC 11 January 2022 Renalytix plc ("Renalytix" or the "Company") Positive Study Results Published for KidneyIntelX TM in Monitoring Patient Response to New Drug Therapy American Journal of Nephrology data demonstrates KidneyIntelX successfully monitors patient
Seventh KidneyIntelX implementation partnership for Renalytix focused on underserved populations with high disease burden GULF COAST, Miss. and SALT LAKE CITY, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Singing River Health System and Renalytix (NASDAQ: RNLX) (LSE: RENX) today announced a partnership to
RNS Number : 8490X Renalytix PLC 10 January 2022 Renalytix plc ("Renalytix" or the "Company") Singing River Health System and Renalytix Join Forces to Improve Kidney Health on the Mississippi Gulf Coast Seventh KidneyIntelX implementation partnership for Renalytix focused on underserved
NEW YORK and SALT LAKE CITY, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced that Jean M. Casner joined the Company this week on January 3, 2022 as Senior Vice President & Chief Human Resources Officer. Ms. Casner will be responsible for Renalytix’s global
RNS Number : 7098X Renalytix PLC 07 January 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix Appoints Jean M. Casner as Chief Human Resources Officer NEW YORK, NY and SALT LAKE CITY, UT January 7, 2022 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced that Jean M.
NEW YORK and SALT LAKE CITY, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (“Renalytix” or the “Company”) today announced the Company will be presenting at the upcoming 40 th Annual J.P. Morgan Virtual Healthcare Conference.
RNS Number : 4318X Renalytix PLC 05 January 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix to Present at 40 th Annual J.P. Morgan Virtual Healthcare Conference LONDON and SALT LAKE CITY , January 5, 2022 - Renalytix plc (LSE: RENX) (NASDAQ: RNLX) today announced the Company
National program establishes early care management, technology innovation and large health system engagement as a strategic priority for supporting the 34 million U.S. individuals living with diabetes ARLINGTON, Va. and SALT LAKE CITY, Jan. 04, 2022 (GLOBE NEWSWIRE) -- The American Diabetes
